However, in ALK- ALCL, only ~20% of ALK- ALCLs have activate mutations of JAK1 and/or STAT3 genes (9), which could not explain the high rate of pSTAT3 positivity both in our study and other researchers’ work (17, 18, 32). This evidence concerns the gene ALK and anaplastic large cell lymphoma.